… reach the CSF and brain tissue and briefly discuss the nasal–… IN delivery of oxytocin for
trigeminal and chronic pain. Lastly, we review the literature on other IN applied polypeptides that …

… reach the CSF and brain tissue and briefly discuss the nasal–… IN delivery of oxytocin for
trigeminal and chronic pain. Lastly, we review the literature on other IN applied polypeptides that …

… contribution of different methods of intranasal application and … functional effects of intranasal
oxytocin and vasopressin in … into the brain following intranasal administration, others may be …

… pain [10]. To date, all randomized clinical trials have chosen to use an intranasal route for
the chronic administration of oxytocin … routes whereby intranasally administered oxytocin can …

… [15a, 15b] In line 27 with this, administration of exogenous OT increases pain perception …
abdominal discomfort and pain under conditions 29 of chronic constipation (intranasal delivery).…

… using intranasal administration of oxytocin, or possibly other … release of PRL, such as
polypeptide PRL-releasing factor, 5-… pain intensity at two hours after intranasal OT administration. …

… or spinal administration. Because of the advantage of intranasal delivery of oxytocin in …
the effect of intranasal application of oxytocin on neuropathic pain and comorbid depressive …

… of oxytocin did not show significant changes in behavior compared with the control group. In
addition, after intranasal administration of oxytocin… of intranasal administration of oxytocin in …

… Background and Purpose: The intranasal administration of oxytocin (OT) reduces … to other
tissue regions [20,24]. We have also shown that intranasal OT inhibits the transmission of pain …

… by showing that a single dose of intranasally administered OT can affect stress regulation and
… Our results suggest that intranasal OT reduced pain experiences to an ecological valid yet …